Dekui Zhang

1.4k total citations
69 papers, 981 citations indexed

About

Dekui Zhang is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dekui Zhang has authored 69 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dekui Zhang's work include Helicobacter pylori-related gastroenterology studies (16 papers), Gut microbiota and health (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Dekui Zhang is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (16 papers), Gut microbiota and health (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Dekui Zhang collaborates with scholars based in China, United States and Belgium. Dekui Zhang's co-authors include Hans Peter Zassenhaus, Justin L. Mott, Qi Zhao, Yuan Sun, Xinyi Lu, Limei Zhao, Guiling Ning, Junwei Ye, Raji Feyisa Bogale and Zehua Feng and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Journal of Medicinal Chemistry.

In The Last Decade

Dekui Zhang

61 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dekui Zhang China 15 410 146 139 125 120 69 981
Dylan K. McDaniel United States 14 405 1.0× 75 0.5× 84 0.6× 127 1.0× 80 0.7× 19 885
Yanhui Zhang China 20 557 1.4× 240 1.6× 172 1.2× 88 0.7× 56 0.5× 90 1.5k
Qingxiang Li China 15 263 0.6× 63 0.4× 64 0.5× 61 0.5× 78 0.7× 61 717
Hongli Chen China 21 377 0.9× 34 0.2× 68 0.5× 122 1.0× 148 1.2× 92 1.3k
Yao Peng China 22 466 1.1× 29 0.2× 182 1.3× 188 1.5× 34 0.3× 74 1.1k
Geng Qin China 19 635 1.5× 52 0.4× 140 1.0× 77 0.6× 18 0.1× 44 1.1k
Jinan Li China 24 409 1.0× 22 0.2× 99 0.7× 90 0.7× 80 0.7× 55 1.2k
Mihai Cenariu Romania 19 213 0.5× 22 0.2× 192 1.4× 169 1.4× 74 0.6× 75 974
Rui Cao China 22 665 1.6× 22 0.2× 134 1.0× 140 1.1× 156 1.3× 92 1.7k

Countries citing papers authored by Dekui Zhang

Since Specialization
Citations

This map shows the geographic impact of Dekui Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dekui Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dekui Zhang more than expected).

Fields of papers citing papers by Dekui Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dekui Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dekui Zhang. The network helps show where Dekui Zhang may publish in the future.

Co-authorship network of co-authors of Dekui Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Dekui Zhang. A scholar is included among the top collaborators of Dekui Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dekui Zhang. Dekui Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Long, et al.. (2025). Targeted DDR1 Treatment Strategy Enhances PD-1 Immunotherapy Efficacy against Gastric Cancer. Journal of Medicinal Chemistry. 68(21). 23573–23588.
3.
Chai, Yan, et al.. (2025). A metagenome-wide association study of gut microbiota in hepatitis B virus-related cirrhosis in northwest China. Frontiers in Genetics. 16. 1619911–1619911.
4.
5.
Li, Muyang, et al.. (2024). Sialylation in the gut: From mucosal protection to disease pathogenesis. Carbohydrate Polymers. 343. 122471–122471. 9 indexed citations
6.
Li, Muyang, et al.. (2024). Nets in fibrosis: Bridging innate immunity and tissue remodeling. International Immunopharmacology. 137. 112516–112516. 11 indexed citations
7.
Gao, Liping, et al.. (2024). NAT10-mediated ac4C modification promotes stemness and chemoresistance of colon cancer by stabilizing NANOGP8. Heliyon. 10(9). e30330–e30330. 7 indexed citations
8.
Zhang, Dekui, et al.. (2023). Focusing on discoidin domain receptors in premalignant and malignant liver diseases. Frontiers in Oncology. 13. 1123638–1123638. 6 indexed citations
9.
Wang, Jinming, Xiaoyun Li, Yanbo Wang, et al.. (2023). Babeisa duncani infection alters gut microbiota profile in hamsters. PubMed. 61(1). 42–52. 3 indexed citations
10.
Huang, Ke, et al.. (2023). Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer. BMC Medical Genomics. 16(1). 123–123. 6 indexed citations
11.
Yang, Xiaoping, Xiaolu Su, Zirui Wang, et al.. (2023). ULBP2 is a biomarker related to prognosis and immunity in colon cancer. Molecular and Cellular Biochemistry. 478(10). 2207–2219. 9 indexed citations
12.
Wang, Li, et al.. (2022). AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer. SHILAP Revista de lepidopterología. 8 indexed citations
13.
Xiong, Bin, et al.. (2022). DDR1 promotes LoVo cell proliferation by regulating energy metabolism. Acta Biochimica et Biophysica Sinica. 54(5). 615–624. 5 indexed citations
14.
Bai, Feihu, et al.. (2022). New target DDR1: A “double-edged sword” in solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(1). 188829–188829. 18 indexed citations
15.
Xu, Fu, Wen Yin, Yifan Yang, et al.. (2021). Shuttle-Shape Carrier-Free Platinum-Coordinated Nanoreactors with O2 Self-Supply and ROS Augment for Enhanced Phototherapy of Hypoxic Tumor. ACS Applied Materials & Interfaces. 13(28). 32690–32702. 21 indexed citations
16.
Li, Muyang, et al.. (2021). Evidence Mapping of Proton Therapy, Heavy Ion Therapy, and Helical Tomotherapy for Gastric Cancer. Oncology Research and Treatment. 44(12). 700–709. 2 indexed citations
17.
Sun, Mingming, Wei Wu, Caiyun Ma, et al.. (2019). MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases. Journal of Autoimmunity. 101. 109–120. 44 indexed citations
18.
Miao, Xin-Pu, Qin Ouyang, Huiyan Li, et al.. (2008). Role of selective cyclooxygenase-2 inhibitors in exacerbation of inflammatory bowel disease: A systematic review and meta-analysis. Current Therapeutic Research. 69(3). 181–191. 10 indexed citations
19.
Mott, Justin L., Dekui Zhang, & Hans Peter Zassenhaus. (2005). Mitochondrial DNA Mutations, Apoptosis, and the Misfolded Protein Response. Rejuvenation Research. 8(4). 216–226. 14 indexed citations
20.
Zhang, Dekui, Uthayashanker Ezekiel, Shin-Wen Chang, & Hans Peter Zassenhaus. (2005). Gene expression profile in dilated cardiomyopathy caused by elevated frequencies of mitochondrial DNA mutations in the mouse heart. Cardiovascular Pathology. 14(2). 61–69. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026